Elizabeth A. Yamashita

Elizabeth A. Yamashita appears in our data through filings on Outlook Therapeutics, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 21 December 2016 to 22 December 2017.

On the market, this insider has only sold: 3 sales, €23k in total. Outside the open market, there are 1 share grant. So far in 2017, the count stands at no purchases and 3 sales.

On 26 December 2017 came the latest disclosure, an open-market sale for €15k in Outlook Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.